World-wide Randomization Antibiotic Envelope Infection Prevention Trial (WRAP-IT)

Recruiting

1 years - 100 years

All

80 participants needed

1 Location

Brief description of study

This study is a single-blinded,randomized,prospective, multi-center clinical trial. The study will evaluate the ability of the TYRX absorable Antibacterial Envelope to reduce major cardiovascular implantable electronic device (CIED) infections. Patients undergoing CIED generator replacement, upgrade, revision or new biventricular defibrillator system will be randomized to receive the TYRX envelope or not to receive the TYRX envelope. A CIED is an implantable defibrillator or pacemaker.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: pacemakers, defibrillators
Age: 1 years - 100 years
Gender: All

Updated on 04 Aug 2024. Study ID: 822098

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

World-wide Randomization Antibiotic Envelope Infection Prevention Trial (WRAP-IT)

Brief description of study

Eligibility of study

Find a site

Interested in the study